课题基金 / 基金详情

Studies on surgical treatment for esophageal carcinoma based on biological characteristics of the cancer cell and immunological response of the patients.

Studies on surgical treatment for esophageal carcinoma based on biological characteristics of the cancer cell and immunological response of the patients.
基于癌细胞生物学特性和患者免疫反应的食管癌手术治疗研究。
批准号:
63570654
负责人:
YAMANA Hideaki
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989

项目摘要

项目成果

YAMANA Hideaki的其他基金

相似基金

相关文献

中文摘要
翻译
对食道癌的生物学特性和免疫反应进行了临床和实验研究。用流式细胞仪检测癌细胞细胞核DNA含量。在这项研究中,与二倍体癌症相比,非整倍体癌症的存活率明显较低。而在根治性手术患者中,除早期癌外,二倍体与非整倍体癌之间差异无统计学意义。用单克隆抗体Ki-67检测增殖的癌细胞。由此可见,Ki-67阳性细胞癌的预后明显差于无Ki-67阳性细胞癌。本研究所研制的KISM-1单抗对食管鳞癌具有较高的亲和力,而在胃和结肠癌中亲和力较低。
英文摘要
Biological characteristics and immnologic response of esophageal carcinoma were studied clinically and experimentally. DNA contents of the cancer cell nuclear were measured by flow cytometry. From this study, aneuploid cancer showed significant poor survival as compared to diploid one. But there were no significances in patients with radical operation except early cancers between diploid and aneuploid cancers. Proliferating cancer cells were measured by monoclonal antibody Ki-67. By this result, the cancer with Ki-67 positive cells showed significant poor prognosis as compared to the cancer without Ki-67 positive cells. Monoclonal antibody of KISM-1 which was produced in our Institute showed high affinity to esophageal squamous cell carcinoma, and a low affinity was recognized in stomach and colonic carcinoma.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
白水玄山: "食道癌における生物学的悪性度ーー最近の研究から" 腫瘍と感染. 1. 1-5 (1988)
Genzan Shiramizu:“食道癌的生物恶性肿瘤 - 来自最近的研究”肿瘤和感染。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
白水玄山: 腫瘍と感染. 1. 1-5 (1988)
Genzan Hakusui:肿瘤和感染。1. 1-5 (1988)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
力武浩: "食道癌細胞の悪性度と生体反応" フロ-サイトメトリ-. 7. 124-128 (1988)
Hiroshi Rikitake:“食管癌细胞的恶性和生物反应”流式细胞术。7. 124-128 (1988)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Rikitake H.: "Malignant potential and immunologic reaction in esophageal cancer" Flowcytometry 7:124-128, 1988.
Rikitake H.:“食道癌的恶性潜能和免疫反应”流式细胞术 7:124-128,1988。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Fundamental study for improvement of cancer immunotherapy based on gene analysis
    • 批准号:
      14370396
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.83万
    • 财政年份:
      2002
    • 负责人:
      YAMANA Hideaki
    • 依托单位:
    Fundamental and clinical research for esophageal cancer rejection peptide antigens as a vaccine therapy
    • 批准号:
      12671282
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      YAMANA Hideaki
    • 依托单位:
    Development of peptide vaccines for HLA-A24ィイD1+ィエD1 esophageal cancer patients.
    • 批准号:
      10671230
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1998
    • 负责人:
      YAMANA Hideaki
    • 依托单位:
    Establishment of tumor specific killer T-cells and the cloning of the tumor rejection antigen gene
    • 批准号:
      08671499
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.47万
    • 财政年份:
      1996
    • 负责人:
      YAMANA Hideaki
    • 依托单位:
    海外基金